Michael J Campbell

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro
    Michael J Campbell
    Department of Surgery and Comprehensive Cancer Center, University of California, San Francisco, CA, USA
    Anticancer Res 22:3843-52. 2002
  2. ncbi request reprint Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse
    Michael J Campbell
    Department of Surgery, University of California San Francisco Mount Zion Medical Center, 1600 Divisadero, San Francisco, CA 94115, USA
    In Vitro Cell Dev Biol Anim 38:326-33. 2002
  3. ncbi request reprint Immune dysfunction and micrometastases in women with breast cancer
    Michael J Campbell
    Department of Surgery, University of California, San Francisco, CA 94115, USA
    Breast Cancer Res Treat 91:163-71. 2005
  4. ncbi request reprint Breast cancer growth prevention by statins
    Michael J Campbell
    Department of Surgery, University of California San Francisco Mt Zion Medical Center, Room C342, 1600 Divisadero, San Francisco, CA 94115, USA
    Cancer Res 66:8707-14. 2006
  5. ncbi request reprint Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells
    Marianna Zavodovskaya
    Diabetes and Endocrine Research, University of California, San Francisco Mt Zion Medical Center, San Francisco, California, USA
    J Cell Biochem 103:624-35. 2008
  6. doi request reprint Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer
    Rita A Mukhtar
    Department of Surgery, University of California, San Francisco, CA, USA
    Ann Surg Oncol 19:3979-86. 2012
  7. doi request reprint Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity
    Rita A Mukhtar
    University of California, San Francisco, San Francisco, CA, USA
    Breast Cancer Res Treat 130:635-44. 2011
  8. ncbi request reprint Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth
    Karissa L Gable
    Diabetes and Endocrine Research University of California, San Francisco Mt Zion Medical Center, Box 1616, San Francisco, CA 94143 1616, USA
    Mol Cancer Ther 5:1079-86. 2006
  9. ncbi request reprint In vitro anticancer activity of twelve Chinese medicinal herbs
    Mark Shoemaker
    Department of Surgery, University of California, San Francisco, CA 94115, USA
    Phytother Res 19:649-51. 2005
  10. pmc The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context
    Michael J Campbell
    Department of Surgery, University of California, San Francisco, San Francisco, California, United States of America
    PLoS ONE 8:e79114. 2013

Collaborators

Detail Information

Publications15

  1. ncbi request reprint Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro
    Michael J Campbell
    Department of Surgery and Comprehensive Cancer Center, University of California, San Francisco, CA, USA
    Anticancer Res 22:3843-52. 2002
    ..These results indicate that many of the herbs used in traditional Chinese medicine for the treatment of cancer have significant growth inhibitory effects on breast cancer cells in vitro...
  2. ncbi request reprint Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse
    Michael J Campbell
    Department of Surgery, University of California San Francisco Mount Zion Medical Center, 1600 Divisadero, San Francisco, CA 94115, USA
    In Vitro Cell Dev Biol Anim 38:326-33. 2002
    ..In addition, the tumor-derived fibroblast line may be useful for studying tumor-stromal cell interactions...
  3. ncbi request reprint Immune dysfunction and micrometastases in women with breast cancer
    Michael J Campbell
    Department of Surgery, University of California, San Francisco, CA 94115, USA
    Breast Cancer Res Treat 91:163-71. 2005
    ..These dysregulated T cell responses did not correlate with age, stage of disease, or nodal status. However, we did observe a correlation between number of micrometastases in the bone marrow and T cell responsiveness...
  4. ncbi request reprint Breast cancer growth prevention by statins
    Michael J Campbell
    Department of Surgery, University of California San Francisco Mt Zion Medical Center, Room C342, 1600 Divisadero, San Francisco, CA 94115, USA
    Cancer Res 66:8707-14. 2006
    ..These findings provide supporting rationale for future statin trials in breast cancer patients...
  5. ncbi request reprint Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells
    Marianna Zavodovskaya
    Diabetes and Endocrine Research, University of California, San Francisco Mt Zion Medical Center, San Francisco, California, USA
    J Cell Biochem 103:624-35. 2008
    ..These studies suggest that NDGA may have therapeutic benefits in HER2-positive, tamoxifen resistant, breast cancers in humans...
  6. doi request reprint Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer
    Rita A Mukhtar
    Department of Surgery, University of California, San Francisco, CA, USA
    Ann Surg Oncol 19:3979-86. 2012
    ..The heterodimeric S100A8/S100A9 complex plays a role in inflammation and is increased in several cancer types...
  7. doi request reprint Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity
    Rita A Mukhtar
    University of California, San Francisco, San Francisco, CA, USA
    Breast Cancer Res Treat 130:635-44. 2011
    ..These findings implicate immune function in the development of aggressive breast cancer and suggest a possible link between SES and the inflammatory response...
  8. ncbi request reprint Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth
    Karissa L Gable
    Diabetes and Endocrine Research University of California, San Francisco Mt Zion Medical Center, Box 1616, San Francisco, CA 94143 1616, USA
    Mol Cancer Ther 5:1079-86. 2006
    ..p. injection thrice a week) reduced the growth rate of MCNeuA cells implanted into mice. These studies indicate that diaryl urea compounds are potential new agents to test in the treatment of breast and other IGF-I-sensitive cancers...
  9. ncbi request reprint In vitro anticancer activity of twelve Chinese medicinal herbs
    Mark Shoemaker
    Department of Surgery, University of California, San Francisco, CA 94115, USA
    Phytother Res 19:649-51. 2005
    ....
  10. pmc The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context
    Michael J Campbell
    Department of Surgery, University of California, San Francisco, San Francisco, California, United States of America
    PLoS ONE 8:e79114. 2013
    ..This, along with the observation that PCNA(+) TAMs were associated predominantly with M1-related genes, may provide new insights into the role of the immune microenvironment in breast cancer...
  11. doi request reprint Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome
    Michael J Campbell
    Department of Surgery, University of California, San Francisco, CA, USA
    Breast Cancer Res Treat 128:703-11. 2011
    ..015). The presence of promacs in human breast cancer may serve as a prognostic indicator for poor outcomes and early recurrence and serve as a potential cellular target for novel therapeutic interventions...
  12. doi request reprint Vandetanib and the management of advanced medullary thyroid cancer
    Michael J Campbell
    Department of Endocrine Surgery, University of California, San Francisco, San Francisco, California, USA
    Curr Opin Oncol 25:39-43. 2013
    ..Vandetanib is a small molecule tyrosine kinase inhibitor that has been recently approved as an 'orphan drug' for the treatment of patients with unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC)...
  13. doi request reprint Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics
    Rita A Mukhtar
    Department of Surgery, University of California, San Francisco, Box 1710 UCSF, San Francisco, CA 94143 1710, USA
    Expert Rev Mol Diagn 11:91-100. 2011
    ..These TAMs are found in high-risk breast cancers, making them an important therapeutic target to explore. Improved techniques for identifying TAMs should translate into clinical applications for prognosis and treatment...
  14. pmc Adrenalectomy outcomes are superior with the participation of residents and fellows
    Carolyn D Seib
    Department of Surgery, University of California, San Francisco, San Francisco, CA Electronic address
    J Am Coll Surg 219:53-60. 2014
    ..The purpose of this study was to determine the association between trainee participation and adrenalectomy perioperative outcomes...
  15. ncbi request reprint Tid1, the human homologue of a Drosophila tumor suppressor, reduces the malignant activity of ErbB-2 in carcinoma cells
    Sung Woo Kim
    Department of Immunology, The Scripps Research Institute, La Jolla, California 92037, USA
    Cancer Res 64:7732-9. 2004
    ..Moreover, the cochaperonic and regulatory functions of Tid1 on HSP70 most likely play an essential role in this antitumor function of Tid1 in carcinoma cells...